Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
5HT1BP282225-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Alzheimer diseaseAnxiety disorderAttention deficit hyperactivity disorderClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
5HT7RP349695-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Alzheimer diseaseAttention deficit hyperactivity disorderBipolar disorderClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
ACHA3P32297Neuronal acetylcholine receptor subunit alpha-3Disease related genesFDA approved drug targetsPredicted intracellular proteins4Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
ACK1Q07912Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2)Cancer-related genesEnzymesPlasma proteinsAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
ACM3P20309Muscarinic acetylcholine receptor M3Disease related genesFDA approved drug targetsG-protein coupled receptors7Abnormal micturitionAlzheimer diseaseAsthmaClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
AP2M1Q96CW1AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein)Disease related genesEssential proteinsHuman disease related genesAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
APLD1Q96LR9Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein)Predicted membrane proteins3Fusion and delivery mediation20.50
AQP5P55064Aquaporin-5 (AQP-5)Disease related genesHuman disease related genesMetabolic proteins6Fusion and delivery mediation20.50
AT2B4P23634Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)EnzymesFDA approved drug targetsMetabolic proteins10Clinical-translation mediationFusion and delivery mediationImmune mediation20.50
ATP4BP51164Potassium-transporting ATPase subunit beta (Gastric H(+)/K(+) ATPase subunit beta) (Proton pump beta chain)FDA approved drug targetsMetabolic proteinsPredicted membrane proteins1Clinical-translation mediationFusion and delivery mediationImmune mediation20.50
CAD15P55291Cadherin-15 (Cadherin-14) (Muscle cadherin) (M-cadherin)Disease related genesHuman disease related genesPredicted membrane proteins1Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation20.50
CADH5P33151Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144)Cancer-related genesCD markersPlasma proteins1Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation20.50
CALRLQ16602Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor) (CRLR)Disease related genesFDA approved drug targetsG-protein coupled receptors7Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
CCD32Q9BV29Coiled-coil domain-containing protein 32Disease related genesHuman disease related genesPredicted intracellular proteinsAdhesion and uptake mediation20.50
CCR4P51679C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD antigen CD194)CD markersFDA approved drug targetsG-protein coupled receptors7AsthmaDiabetes mellitusImmune system diseaseClinical-translation mediationFusion and delivery mediationImmune mediation20.50
CD28P10747T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28)CD markersPredicted membrane proteins1Brain cancerDiabetes mellitusImmune system diseaseAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50
CD38P28907ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPR hydrolase 1) (T10) (CD antigen CD38)Cancer-related genesCD markersEnzymes1Acute myeloid leukaemiaB-cell lymphomaMalignant haematopoietic neoplasmClinical-translation mediationFusion and delivery mediationImmune mediation20.50
CD3GP09693T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g)CD markersDisease related genesFDA approved drug targets1Breast cancerColorectal cancerMalignant digestive organ neoplasmClinical-translation mediationFusion and delivery mediationImmune mediation20.50
CLCN6P51797H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6)Disease related genesPlasma proteinsPredicted membrane proteins10Clinical-translation mediationFusion and delivery mediation20.50
CNR1P21554Cannabinoid receptor 1 (CB-R) (CB1) (CANN6)Disease related genesFDA approved drug targetsG-protein coupled receptors7Clinical-translation mediationFusion and delivery mediationImmune mediation20.50
CYBC1Q9BQA9Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros)Disease related genesHuman disease related genesPredicted intracellular proteins1Other mediation20.50
DIAP1O60610Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1)Cancer-related genesDisease related genesHuman disease related genesFusion and delivery mediationImmune mediationMetabolism mediation20.50
DOCK8Q8NF50Dedicator of cytokinesis protein 8Disease related genesHuman disease related genesPredicted intracellular proteinsAdhesion and uptake mediationImmune mediationReceptor-signaling mediation20.50
EDNRBP24530Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type)Disease related genesFDA approved drug targetsG-protein coupled receptors7Cardiac arrhythmiaCardiovascular diseaseEncephalopathyClinical-translation mediationFusion and delivery mediationImmune mediation20.50
EPHB2P29323Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2]Cancer-related genesDisease related genesEnzymes1Kaposi sarcomaMelanomaPancreatic cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation20.50

176-200 of 792 proteins

Page